Mar 12, 2024 / 12:00PM GMT
Operator
Good morning, and welcome to the BioXcel Therapeutics conference call, which will include an update on the company's late-stage clinical programs and the discussion of financial results for the fourth quarter and full year 2023. (Operator Instructions)
Just to remind everyone, certain matters discussed in today's conference call and or answers that may be given to questions asked are forward-looking statements subject to risks and uncertainties related to future events and or the future financial or business performance of the Company. Actual results could differ materially from those anticipated in those forward-looking statements.
Risk factors that may affect future results are detailed in the Company's quarterly report on Form 10-Q for the quarter ended September 30, 2023, which can be found at www.BioXcelTherapeutics.com or on www.SEC.gov and which will be updated in its annual report on Form 10-K for the year ended December 31, 2023. As a reminder,
Q4 2023 BioXcel Therapeutics Inc Earnings Call Transcript
Mar 13, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers